1. When we use LMA for airway management replace endotracheal tube, we can decreased the incidence of PRAE in pediatric patients with URI 2. The incidence of PRAE in Deep LMA removal is less than Awake technique 3. Dexmedetomidine IV can decreased the need of sevoflurane for Deep LMA removal 1. Dexmedetomidine intravenous injection 2. Deep LMA removal 3. End tidal sevoflurane
Conditions
Interventions
We will control the end tidal sevoflurane to level 1.07% and continue ventilate patients with this level about 10 minutes before test the level of anesthesia. If level of anesthesia is in deep level,
Experimental Drug,Active Comparator Drug
End tidal sevoflurane 1.07%,End tidal sevoflurane 2.4%
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
3 Years to 7 Years
Inclusion criteria
Inclusion criteria: 1. Age 3-7 yrs. 2. ASA physical status 1-2 3. Undergoing unilateral inguinal hernia repair/herniotomy at Han hospital 4. Surgery under anesthesia technique : General anesthesia with LMA with spontaneous ventilation with QLB type 2
Exclusion criteria
Exclusion criteria: 1. Obesity 2. Difficult airway is predicted 3. Allergy to : Midazolam, Fentanyl, Propofol, Dexmedetomidine, Bupivacaine, Ondansetron 4. Full stomach 5. Bradycardia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Smooth Laryngeal airway removal Emergence period, at post anesthetic care unit Incidence of perioperative respiratory adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of perioperative adverse events Emergence, at post anesthetic care unit Incidence of perioperative adverse events | — |
Countries
Thailand
Contacts
Public ContactKanokphol Singtana
Department of anesthesia, Nan hospital
Outcome results
None listed